Literature DB >> 19681764

Use of the retinal vessel analyzer in ocular blood flow research.

Gerhard Garhofer1, Toke Bek, Andreas G Boehm, Doina Gherghel, Juan Grunwald, Peter Jeppesen, Hélène Kergoat, Konstantin Kotliar, Ines Lanzl, John V Lovasik, Edgar Nagel, Walthard Vilser, Selim Orgul, Leopold Schmetterer.   

Abstract

The present article describes a standard instrument for the continuous online determination of retinal vessel diameters, the commercially available retinal vessel analyzer. This report is intended to provide informed guidelines for measuring ocular blood flow with this system. The report describes the principles underlying the method and the instruments currently available, and discusses clinical protocol and the specific parameters measured by the system. Unresolved questions and the possible limitations of the technique are also discussed.
© 2009 The Authors. Journal compilation © 2009 Acta Ophthalmol.

Mesh：

Year:  2010        PMID： 19681764     DOI： 10.1111/j.1755-3768.2009.01587.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


  71 in total

1.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

2.  Dynamics of retinal vessel response to flicker light in glaucoma patients and ocular hypertensives.

Authors:  K Gugleta; A Kochkorov; N Waldmann; A Polunina; R Katamay; J Flammer; S Orgul
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-19       Impact factor: 3.117

3.  Inter-method agreement in retinal blood vessels diameter analysis between Dynamic Vessel Analyzer and optical coherence tomography.

Authors:  Lucia Benatti; Federico Corvi; Livia Tomasso; Stefano Mercuri; Lea Querques; Fulvio Ricceri; Francesco Bandello; Giuseppe Querques
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-11       Impact factor: 3.117

4.  The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.

Authors:  Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-07       Impact factor: 3.117

5.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

6.  Reliability of vessel diameter measurements with a retinal oximeter.

Authors:  Renata Blondal; Margret Kara Sturludottir; Sveinn Hakon Hardarson; Gisli Hreinn Halldorsson; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-16       Impact factor: 3.117

7.  Blood flow velocity vector field reconstruction from dual-beam bidirectional Doppler OCT measurements in retinal veins.

Authors:  Gerold C Aschinger; Leopold Schmetterer; Veronika Doblhoff-Dier; Rainer A Leitgeb; Gerhard Garhöfer; Martin Gröschl; René M Werkmeister
Journal:  Biomed Opt Express       Date:  2015-04-06       Impact factor: 3.732

Review 8.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

9.  Lack of effect of nitroglycerin on the diameter response of larger retinal arterioles in normal persons during hypoxia.

Authors:  Musa Yasin Kaya; Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-30       Impact factor: 3.117

10.  Retinal blood flow in type 1 diabetic patients with no or mild diabetic retinopathy during euglycemic clamp.

Authors:  Berthold Pemp; Elzbieta Polska; Gerhard Garhofer; Michaela Bayerle-Eder; Alexandra Kautzky-Willer; Leopold Schmetterer
Journal:  Diabetes Care       Date:  2010-06-28       Impact factor: 17.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.